Aug 6, 2026 07:39AM
Aug 5, 2026 06:17PM
Jul 9, 2026 06:47AM
Jun 29, 2026 07:02AM
Jun 8, 2026 04:07PM
Jun 2, 2026 06:42AM
May 12, 2026 03:03AM Guggenheim Starts Enliven Therapeutics (ELVN) at Buy
Apr 8, 2026 07:12AM
Mar 26, 2026 06:43AM
Mar 25, 2026 10:04AM
Mar 25, 2026 07:39AM
Mar 24, 2026 03:04PM
Mar 3, 2026 04:36PM
Jan 7, 2026 09:03AM Enliven Therapeutics adds Scott Garland to board, Andrew Phillips resigns
Dec 11, 2025 09:01AM
Nov 12, 2025 04:43PM
Aug 14, 2025 05:33AM
Aug 13, 2025 06:05PM
Jul 2, 2025 06:38AM
Jun 20, 2025 10:31AM
Jun 16, 2025 05:14AM Goldman Sachs Starts Enliven Therapeutics (ELVN) at Buy
Jun 13, 2025 09:31AM
Jun 13, 2025 06:15AM
Jun 13, 2025 06:03AM
May 30, 2025 06:37AM
May 16, 2025 12:21PM
May 15, 2025 06:48AM
May 14, 2025 04:14PM Enliven Therapeutics, Inc (ELVN) Misses Q1 EPS by 7c
May 14, 2025 09:58AM
Mar 13, 2025 04:12PM
Dec 13, 2024 06:02AM
Dec 12, 2024 01:15PM
Nov 15, 2024 07:20AM
Nov 13, 2024 09:04PM
Oct 30, 2024 04:13PM Jones Trading Starts Enliven Therapeutics (ELVN) at Buy
Oct 2, 2024 06:43AM
Oct 1, 2024 07:13AM
Sep 30, 2024 08:38AM
Sep 23, 2024 11:00AM
Sep 9, 2024 06:32AM
Aug 19, 2024 06:42AM
Aug 14, 2024 11:08AM TD Cowen Reiterates Buy Rating on Enliven Therapeutics (ELVN)
Jun 11, 2024 05:06AM

435,847 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All